Christopher Gibson
CEO at Recursion Pharmaceuticals, Inc. (RXRX); Director at Recursion Pharmaceuticals, Inc. (RXRX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 5SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000883,735 held (−4%) | $3.62 | $145K | +20.4% |
| May 27SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000883,735 held (−4%) | $3.08 | $123K | +41.6% |
| May 8SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000926,556 held (−4%) | $3.37 | $135K | +29.4% |
| Apr 24SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000906,556 held (−4%) | $3.61 | $144K | +20.8% |
| Apr 8SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000906,556 held (−4%) | $3.10 | $124K | +40.6% |
| Mar 25SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000906,556 held (−4%) | $3.25 | $130K | +34.2% |
| Feb 19SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000906,556 held (−4%) | $3.46 | $138K | +26.0% |
| Feb 6SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000913,839 held (−4%) | $4.12 | $165K | +5.8% |
| Jan 22SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000913,839 held (−4%) | $4.47 | $179K | -2.5% |
| Jan 7SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000933,839 held (−4%) | $4.25 | $170K | +2.6% |
| Dec 19SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000913,839 held (−4%) | $4.50 | $180K | -3.1% |
| Dec 5SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000933,839 held (−4%) | $4.63 | $185K | -5.8% |
| Nov 19SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000913,839 held (−4%) | $4.16 | $166K | +4.8% |
| Nov 6SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,000974,229 held (−4%) | $5.21 | $208K | -16.3% |
| Oct 24SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 100,000954,229 held (−9%) | $5.70 | $570K | -23.5% |
| Oct 10SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 100,000974,229 held (−9%) | $6.04 | $604K | -27.8% |
- Sell
Director Christopher Gibson sold $145K of RXRX at $3.62 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher Gibson sold $123K of RXRX at $3.08 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher Gibson sold $135K of RXRX at $3.37 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher Gibson sold $144K of RXRX at $3.61 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher Gibson sold $124K of RXRX at $3.10 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher Gibson sold $130K of RXRX at $3.25 — pre-scheduled 10b5-1 plan sale.